The thesis of increased—stimulated by MMPs—degradation of PGs/GAGs in the course of JIA is confirmed by significantly higher concentrations of MMP-1 and MMP-3 in the blood of patients with active arthropathy, who qualified for ETA therapy. The gene discussed is MMP3; the disease is arthropathy.